Adam Friedler and Ohad Sandler are co-CEOs of the Good Pharm chain. Friedler: "The market in Israel is super-concentrated.

There are such large categories here that 100% market share is divided between 3-2 suppliers" "The state is the main beneficiary of the wave of price increases," says Sandler. "People with salaries of tens of thousands of shekels in Israel are not easy for them, and it's delusional," says Friedler.